Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study

被引:0
作者
Robert P. Cowan
Michael J. Marmura
Hans-Christoph Diener
Amaal J. Starling
Jack Schim
Joe Hirman
Thomas Brevig
Roger Cady
机构
[1] Stanford Health Care,
[2] Jefferson Headache Center,undefined
[3] Medical Faculty of the University Duisburg-Essen,undefined
[4] Institute for Medical Informatics,undefined
[5] Biometry and Epidemiology,undefined
[6] Mayo Clinic Arizona,undefined
[7] The Neurology Center of Southern California,undefined
[8] Pacific Northwest Statistical Consulting,undefined
[9] Inc.,undefined
[10] H. Lundbeck A/S,undefined
[11] Lundbeck LLC,undefined
[12] RK Consults,undefined
[13] Missouri State University,undefined
来源
The Journal of Headache and Pain | 2022年 / 23卷
关键词
Chronic migraine; Eptinezumab; Medication-overuse headache; Serotonin 5-HT; receptor agonists; Analgesics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 163 条
[1]  
Lipton RB(2002)Migraine in the United States: epidemiology and patterns of health care use Neurology 58 885-894
[2]  
Scher AI(2019)Unmet acute treatment needs from the 2017 migraine in America symptoms and treatment study Headache 59 1310-1323
[3]  
Kolodner K(2018)Migraine in America Symptoms and Treatment (MAST) study: baseline study methods, treatment patterns, and gender differences Headache 58 1408-1426
[4]  
Lipton RB(2020)Characterization of acute prescription migraine medication use: results from the CaMEO study Mayo Clin Proc 95 709-718
[5]  
Munjal S(2015)Drug safety in acute migraine treatment Expert Opin Drug Saf 14 891-909
[6]  
Buse DC(2017)Comparative tolerability of treatments for acute migraine: a network meta-analysis Cephalalgia 37 965-978
[7]  
Lipton RB(2018)Medication-overuse headache: a widely recognized entity amidst ongoing debate J Headache Pain 19 1-14
[8]  
Munjal S(2018)The international classification of headache disorders, 3rd edition Cephalalgia 38 1-211
[9]  
Alam A(2019)Pathophysiology, prevention, and treatment of medication overuse headache Lancet Neurol 18 891-902
[10]  
Hutchinson S(2016)Risk of medication overuse headache across classes of treatments for acute migraine J Headache Pain 17 107-1039